Secretion of tumor necrosis factor-alpha by mouse peritoneal macrophages in the presence of dental sealers, sealapex and endomethasone.
After filling root canals, the healing process depends on the chemical composition or physical-chemical properties of the material used, among other factors. All root canal sealers, whether solid or plastic, are foreign matter for the body if they remain in permanent contact with apical and periapical tissues. As a result, the first organic reaction that occurs is an attempt to phagocytize the material. During phagocytosis, macrophages release a large number of cell mediators into the area, among which are cytokines that are essential in intercellular communication and in many physiological and pathophysiological processes. One of these cytokines is tumor necrosis factor-alpha (TNF-alpha), which acts through links to specific receptors on the cell membrane initiating a cascade of events leading to induction, activation, or inhibition of numerous cytokine-regulated genes in the cell nucleus. The release of TNF-alpha in a cell culture of mouse peritoneal macrophages incubated with three concentrations (25, 50, and 100 mg/ml) of two endodontic sealers was measured. The solutions containing the calcium hydroxide-based root canal sealer (Sealapex) released fewer units of TNF-alpha than solutions containing the zinc oxide and eugenol-based sealer (Endomethasone).
Perassi
Fábio Tobias
FT
Endodontics and Integrated Clinical Medicine I, Dental School of Lins, (UNIMEP), Lins, SP, Brazil.
Filho
Idomeo Bonetti
IB
Berbert
Fábio Luis Camargo Villela
FL
Carlos
Iracilda Zeppone
IZ
de Toledo Leonardo
Renato
R
D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology; D002126:Calcium Hydroxide / Q000494:pharmacology*; D002478:Cells, Cultured; D004396:Coloring Agents; D003907:Dexamethasone / Q000494:pharmacology*; D004338:Drug Combinations; D005260:Female; D005557:Formaldehyde / Q000494:pharmacology*; D005840:Gentian Violet; D006854:Hydrocortisone / Q000494:pharmacology*; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D010587:Phagocytosis / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor / Q000187:drug effects / Q000235:genetics; D012387:Root Canal Filling Materials / Q000494:pharmacology*; D012459:Salicylates / Q000494:pharmacology*; D013943:Thymol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism
D001672:Biocompatible Materials; D004396:Coloring Agents; D004338:Drug Combinations; D018124:Receptors, Tumor Necrosis Factor; D012387:Root Canal Filling Materials; D012459:Salicylates; D014409:Tumor Necrosis Factor-alpha; C011244:corticosteroid methanetriol mixture; C055601:Sealapex; D005557:Formaldehyde; D013943:Thymol; D003907:Dexamethasone; D005840:Gentian Violet; D002126:Calcium Hydroxide; D006854:Hydrocortisone